Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis
Authors:
- 1 July 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of Hepatology
- Vol. 25 (1) , 49-57
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Ursodiol for the Long-Term Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1994
- Ursodeoxycholic acid in the treatment of primary biliary cirrhosisGastroenterology, 1994
- A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosisJournal of Gastroenterology and Hepatology, 1994
- Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosisJournal of Hepatology, 1994
- Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid aloneJournal of Hepatology, 1993
- Ursodeoxycholic acid for symptomatic primary biliary cirrhosisJournal of Hepatology, 1993
- A controlled trial of prednisolone treatment in primary biliary cirrhosisJournal of Hepatology, 1992
- A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1991
- A multi-center double-blind controlled trial of ursodeoxycholic acid for primary biliary cirrhosisGastroenterologia Japonica, 1990
- Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trialGastroenterology, 1989